LUNGevity Foundation· @LUNGevity · X·· 2026-04-19Score60
Reading
Lung cancer: perioperative IO and KRAS NSCLC
Body
With prostate cancer leading the way, radiopharmaceutical therapies are transforming how we treat cancer with precision.
@ZachMorrisMDPhD
@UWMadison
provides a great landscape view of the advantages + disadvantages of RPTs including manufacturing issues. #AACR26 #lcsm
Heat 2 · 0 likes · 0 replies · 2 reposts
Source: LUNGevity Foundation · x.com
